The MarketReader Minute
đź’Š IBB Rises on Sector Optimism and Fed Rate Cut Signals | Biotech Sector Insights
(IBB) is up since Tuesday, buoyed by renewed investor optimism. Vertex, Gilead, Rhythm Pharma, BioMarin, and PCVX led gains, with Rhythm jumping on strong Phase 2 trial data.